Paula Wells

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 303 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer

Nicholas van As, Clare Griffin, Alison Tree et al. · New England Journal of Medicine · 2024 · 218 citations · Full text

Medicine, Radiation Oncology, Urology +16

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

Justin Stebbing, Thomas Powles, Kirsty McPherson et al. · Lung Cancer · 2008 · 151 citations

Medicine, Oncology, Pharmacology +12

Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies.

Paula Wells, Roger N. Gunn, Malcolm Alison et al. · PubMed · 2002 · 74 citations

Medicine, Nuclear Medicine, Oncology +15